ASCO and CAP Guidelines for HER2 Testing

Below, find the clinical practice guideline update from ASCO and CAP (October 2013) on Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.

Dako recommends that laboratories follow the instructions described in the package insert for the FDA-approved kit. Following other guidelines than those recommended in the package insert is on the discretion of the lab director.

ASCO and CAP Guidelines for Her2 Testing

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.

Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement

Get in Touch with Dako in


Submit an Inquiry

How would you like us to follow up?

Your session expired

You have been logged out. Log in again to retrieve your Cart.